Adeona Nabs Another $400k In Grant Money

3/28/11

Adeona Pharmaceuticals (AMEX:AEN) said Monday that it received another $409,426 in grant money from the National Multiple Sclerosis Society. The Ann Arbor, MI-based company is currently conducting a clinical trial of its Trimesta drug to treat female MS.

By posting a comment, you agree to our terms and conditions.